How is blood component processing?

Leukoreduction is a process implemented in modern blood banking to reduce the number of white blood cells (WBCs) in blood products, including red blood cells (RBCs) and platelets. The primary goal of leukoreduction is to decrease the risk of transfusion-related complications, such as febrile non-hemolytic reactions, alloimmunization, and transmission of infectious agents carried by white blood cells. Leukoreduction also helps mitigate the inflammatory response associated with transfusion, particularly in immunocompromised or critically ill patient